Document
IPR2017-00807, No. 1011-10 Exhibit - European Patent Application No 0780127 (P.T.A.B. Feb. 2, 2017)
Cite Document
IPR2017-00807, No. 1011-10 Exhibit - European Patent Application No 0780127 (P.T.A.B. Feb. 2, 2017)
+ More Snippets
Document
IPR2017-00807, No. 2051-118 Exhibit - Physicians Desk Reference, 54th ed, pp 2783 2786 2000 (P.T.A.B. May. 30, 2017)
Cite Document
IPR2017-00807, No. 2051-118 Exhibit - Physicians Desk Reference, 54th ed, pp 2783 2786 2000 (P.T.A.B. May. 30, 2017)
+ More Snippets
Document
IPR2017-00807, No. 2081-126 Exhibit - FDAgov, First Time Generic Drug Approvals March 2016, accessed June 28, 2016 PTX0424 (P.T.A.B. May. 30, 2017)
Cite Document
IPR2017-00807, No. 2081-126 Exhibit - FDAgov, First Time Generic Drug Approvals March 2016, accessed June 28, 2016 PTX0424 (P.T.A.B. May. 30, 2017)
+ More Snippets
Document
IPR2017-00807, No. 2101-146 Exhibit - Apotex Press Release Apotex Launches First Generic Version of Mercks Nasonex¿¿, dated March 24, 2016 (P.T.A.B. May. 30, 2017)
Cite Document
IPR2017-00807, No. 2101-146 Exhibit - Apotex Press Release Apotex Launches First Generic Version of Mercks Nasonex¿¿, dated March 24, 2016 (P.T.A.B. May. 30, 2017)
+ More Snippets
Document
IPR2017-00807, No. 2079-124 Exhibit - 20111102 Email and attachment from Ashwini Dumaswala to Bryan Roecklein re 2012 Dymista¿¿ Strategy Plan PTX0267 (P.T.A.B. May. 30, 2017)
Cite Document
IPR2017-00807, No. 2079-124 Exhibit - 20111102 Email and attachment from Ashwini Dumaswala to Bryan Roecklein re 2012 Dymista¿¿ Strategy Plan PTX0267 (P.T.A.B. May. 30, 2017)
+ More Snippets
Document
IPR2017-00807, No. 1042-41 Exhibit - Schleimer, R (P.T.A.B. Feb. 2, 2017)
Cite Document
IPR2017-00807, No. 1042-41 Exhibit - Schleimer, R (P.T.A.B. Feb. 2, 2017)
+ More Snippets
Document
IPR2017-00807, No. 1003-55 Exhibit - Declaration of Dr Robert Schleimer (P.T.A.B. Feb. 2, 2017)
Cite Document
IPR2017-00807, No. 1003-55 Exhibit - Declaration of Dr Robert Schleimer (P.T.A.B. Feb. 2, 2017)
+ More Snippets
Document
IPR2017-00807, No. 2110-151 Exhibit - Kibbe 2000 PTX0198 (P.T.A.B. May. 30, 2017)
Cite Document
IPR2017-00807, No. 2110-151 Exhibit - Kibbe 2000 PTX0198 (P.T.A.B. May. 30, 2017)
+ More Snippets
Document
IPR2017-00807, No. 1001 Exhibit - US Patent No 8,168,620 (P.T.A.B. Feb. 2, 2017)
Cite Document
IPR2017-00807, No. 1001 Exhibit - US Patent No 8,168,620 (P.T.A.B. Feb. 2, 2017)
+ More Snippets
Document
IPR2017-00807, No. 2058-103 Exhibit - 20060321 Email and attachment from Kalidas Kale to Alex DAddio re Astelin ¿¿¿ Flonase Combination Product Feasibility Assessment Plan PTX0151 (P.T....
Cite Document
IPR2017-00807, No. 2058-103 Exhibit - 20060321 Email and attachment from Kalidas Kale to Alex DAddio re Astelin ¿¿¿ Flonase Combination Product Feasibility Assessment Plan PTX0151 (P.T.A.B. May. 30, 2
+ More Snippets
Document
IPR2017-00807, No. 2047-93 Exhibit - Blaiss 2001 PTX0058 (P.T.A.B. May. 30, 2017)
Cite Document
IPR2017-00807, No. 2047-93 Exhibit - Blaiss 2001 PTX0058 (P.T.A.B. May. 30, 2017)
+ More Snippets
Document
IPR2017-00807, No. 1072-231 Exhibit - Brozek (P.T.A.B. Mar. 6, 2018)
Cite Document
IPR2017-00807, No. 1072-231 Exhibit - Brozek (P.T.A.B. Mar. 6, 2018)
+ More Snippets
Document
IPR2017-00807, No. 1123-282 Exhibit - Beconase AQ (P.T.A.B. Mar. 6, 2018)
Cite Document
IPR2017-00807, No. 1123-282 Exhibit - Beconase AQ (P.T.A.B. Mar. 6, 2018)
+ More Snippets
Document
IPR2017-00807, No. 1062-221 Exhibit - Cetirizine Levocetirizine (P.T.A.B. Mar. 6, 2018)
Cite Document
IPR2017-00807, No. 1062-221 Exhibit - Cetirizine Levocetirizine (P.T.A.B. Mar. 6, 2018)
+ More Snippets
Document
IPR2017-00807, No. 1124-283 Exhibit - McDuff (P.T.A.B. Mar. 6, 2018)
Cite Document
IPR2017-00807, No. 1124-283 Exhibit - McDuff (P.T.A.B. Mar. 6, 2018)
+ More Snippets